BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38754651)

  • 1. A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease.
    Rahman A; Haider MF
    Steroids; 2024 Jul; 207():109440. PubMed ID: 38754651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoids and osteoporosis].
    Zikán V
    Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
    Lems WF; Saag K
    Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and management of osteoporosis due to inhaled, epidural, intra-articular or topical glucocorticoids.
    Anastasilakis AD; Naciu AM; Yavropoulou MP; Paccou J
    Joint Bone Spine; 2023 Dec; 90(6):105604. PubMed ID: 37399940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for steroid-induced osteoporosis.
    Allen CS; Yeung JH; Vandermeer B; Homik J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
    Goldstein MF; Fallon JJ; Harning R
    Chest; 1999 Dec; 116(6):1733-49. PubMed ID: 10593801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Glucocorticoid Induced Osteoporosis.
    Cho SK; Sung YK
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):536-543. PubMed ID: 34107602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-Induced Osteoporosis.
    Frenkel B; White W; Tuckermann J
    Adv Exp Med Biol; 2015; 872():179-215. PubMed ID: 26215995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.
    Raterman HG; Bultink IEM; Lems WF
    Drugs; 2019 Jul; 79(10):1065-1087. PubMed ID: 31201710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.
    Chiodini I; Falchetti A; Merlotti D; Eller Vainicher C; Gennari L
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):283-298. PubMed ID: 32584619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis].
    Tanaka I
    Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
    Kaji H; Yamauchi M; Chihara K; Sugimoto T
    Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management.
    Anastasilaki E; Paccou J; Gkastaris K; Anastasilakis AD
    Hormones (Athens); 2023 Dec; 22(4):611-622. PubMed ID: 37755658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.
    Ward LM
    Front Endocrinol (Lausanne); 2020; 11():576. PubMed ID: 33391179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid and Bone. Pathogenesis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2014 Sep; 24(9):1289-94. PubMed ID: 25177000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.
    Hayes KN; Baschant U; Hauser B; Burden AM; Winter EM
    Front Endocrinol (Lausanne); 2021; 12():782118. PubMed ID: 34975756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid and Bone. Fracture risk of steroid-induced osteoporosis].
    Fujiwara S
    Clin Calcium; 2014 Sep; 24(9):1295-300. PubMed ID: 25177001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.